The GnRH agonist protocol, which is also associated with an increased risk of OHSS when compared to a GnRH antagonist protocol [77], cannot be used in conjunction with a GnRH agonist trigger. Here, GNRH1 is linked to ovarian hyperstimulation syndrome.